Clinical Trial Imaging Market Growth Shaped by Oncology and Neurology
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologies for accurate disease diagnosis and treatment monitoring. Rising demand for efficient, non-invasive, and real-time assessment in drug development further drives market expansion.
The clinical trial imaging market is valued at USD 2.62 billion in 2025 and is on track to reach USD 5.58 billion by 2034, witnessing a steady CAGR of 8.8% during the forecast span.
North America is currently leading the clinical trial imaging market share 42% due to its mature clinical research ecosystem and high concentration of specialized imaging centers.
The clinical trial imaging market includes five segments by service type, by imaging modality, by therapeutic area, by end user, and by region.
Key trends include the growth due to the increasing adoption of advanced imaging technologies for accurate disease diagnosis and treatment monitoring.
India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Download Sample
Order Now
.webp){kind=small}
Report Description